AAAntonia Rodriguez Agarrabeitia

Antonia Rodriguez Agarrabeitia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Antonia Rodriguez Agarrabeitia has a total of 111 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A highly fluorescent and readily accessible all-organic photosensitizer model for advancing image-guided cancer PDT

    by Andres Garcia-Sampedro, Alejandro Prieto-Castañeda, Antonia R. Agarrabeitia, Jorge Bañuelos, Inmaculada García-Moreno, Angeles Villanueva, Santiago de la Moya, María J. Ortiz, Pilar Acedo

    A simple model for advancing the rapid construction of heavy-atom-free image-guided PDT agents for cancer treatment has been developed on the basis of using mitochondria targeting and BODIPY chemistry.


  • Generation of multiple triplet states in an orthogonal bodipy dimer: a breakthrough spectroscopic and theoretical approach

    by Inmaculada García-Moreno, Verònica Postils, Esther Rebollar, Maria J. Ortiz, Antonia R. Agarrabeitia, David Casanova

    Mechanistic details of multiple deactivation channels for the triplet state generation and delayed luminescence in an orthogonal BODIPY dimer.


  • Open Access

    Influence of At-Bridge Nitro Groups on the Photophysics and Chiroptics of helicoBODIPYs: A Step Forward towards the Development of New Chiroptical Sensors

    by César Ray, Carolina Díaz-Norambuena, Christopher Schad, Florencio Moreno, Antonia R. Agarrabeitia, María J. Ortiz, Teresa Arbeloa, Jorge Bañuelos, Beatriz L. Maroto, Santiago de la Moya

    A new helicoBODIPY (bisBODIPY with helical chirality) with nitro groups at the chiral bridge has been synthesized as a model to study the influence of the at-bridge substitution on the photophysics and chiroptics of the helicoBODIPY. This preliminary study reveals that at-bridge substitution can be a strategy for the development of chiroptical sensors based on helicoBODIPYs.

  • Open Access

    Exploring New Mitochondria-Targetable Theragnostic styrylBODIPYs

    by Tania Mazuelo, Sergio Serrano, Fernando García-Garrido, Josué Jiménez, Carolina Díaz-Norambuena, Beatriz L. Maroto, Florencio Moreno, Jorge Bañuelos, Antonia R. Agarrabeitia, Ángeles Villanueva, et al.

    Two analogs of a previous mitochondria-targetable theragnostic styrylBODIPY have been designed, synthesized, and submitted to preliminary studies in order to explore their capability to act as new theragnostic agents with absorption in the red region. The new dyes are obtained through a straightforward and low-cost synthetic protocol and have styryl moieties bearing non-delocalized cations (trimethylammonium) attached to the BODIPY through a spacer, or directly linked. Preliminary results of them in cell bioimaging showed internalization into HeLa cells and accumulation into mitochondria. Photodynamic therapy was also analyzed, demonstrating the viability of this red styrylBODIPY as mitochondria-targetable photo-theragnostic agent.


  • Open Access

    Exploring BODIPY Derivatives as Singlet Oxygen Photosensitizers for PDT

    by Ruth Prieto‐Montero, Alejandro Prieto‐Castañeda, Rebeca Sola‐Llano, Antonia R. Agarrabeitia, David García‐Fresnadillo, Iñigo López‐Arbeloa, Angeles Villanueva, María J. Ortiz, Santiago de la Moya, Virginia Martínez‐Martínez

    This minireview is devoted to honoring the memory of Dr. Thomas Dougherty, a pioneer of modern photodynamic therapy (PDT). It compiles the most important inputs made by our research group since 2012 in the development of new photosensitizers based on BODIPY chromophore which, thanks to the rich BODIPY chemistry, allows a finely tuned design of the photophysical properties of this family of dyes to serve as efficient photosensitizers for the generation of singlet oxygen. These two factors, photophysical tuning and workable chemistry, have turned BODIPY chromophore as one of the most promising dyes for the development of improved photosensitizers for PDT. In this line, this minireview is mainly related to the establishment of chemical methods and structural designs for enabling efficient singlet oxygen generation in BODIPYs. The approaches include the incorporation of heavy atoms, such as halogens (iodine or bromine) in different number and positions on the BODIPY scaffold, and also transition metal atoms, by their complexation with Ir(III) center, for instance. On the other hand, low‐toxicity approaches, without involving heavy metals, have been developed by preparing several orthogonal BODIPY dimers with different substitution patterns. The advantages and drawbacks of all these diverse molecular designs based on BODIPY structural framework are described.


  • Open Access

    Tailoring the Molecular Skeleton of Aza‐BODIPYs to Design Photostable Red‐Light‐Emitting Laser Dyes

    by Alejandro Prieto‐Castañeda, Edurne Avellanal‐Zaballa, Leire Gartzia‐Rivero, Luis Cerdán, Antonia Rodriguez Agarrabeitia, Inmaculada García‐Moreno, Jorge Bañuelos, Maria Jose Ortiz

    In this article the design and characterization of a set of novel red‐light‐emitting laser aza‐BODIPY dyes is reported. The applied synthetic method allows an exhaustive and versatile functionalization of both the dipyrrin core and the boron bridge. From the analysis of the photophysical and laser signatures, we determine the suitable modifications of the chromophoric backbone necessary to modulate the emission spectral region, efficiency and photostability under a strong irradiation regime. These dyes are endowed with efficient fluorescence and laser emission, and are particularly outstanding in terms of their high photostability, a key parameter to guarantee long‐lasting emission in any (bio)technological application. The herein‐reported results support, for the first time, the viability of aza‐BODIPYs as tunable red laser dyes. In fact, the laser performances of some of the tested aza‐BODIPYs surpass those of commercially available laser dyes in the same spectral region.


  • Open Access

    Exploring BODIPY meso-enamines as singlet-oxygen photosensitizers for PDT

    by Maria J. Ortiz, Antonia R. Agarrabeitia, Eduardo Palao, Ruth Prieto-Moreno, Nerea Epelde-Elezcano, Florencio Moreno, Virginia Martinez-Martinez, Santiago de la Moya, Alejandro Prieto-Castañeda, Beatriz L. Maroto

    We have recently reported on the control of Vilsmeier-Haack processes in meso-methylBODIPYs with activated DMF as the electrophilic reagent.1 Such a control allows the selective generation of beta-formylBODIPYs, BODIPY meso-enamines or BODIPY meso-iminium/enamine salts, by selecting properly the substitution pattern in the starting BODIPY, the hard (or soft) nature of the activated-DMF reagent, as well as the reaction conditions.1 It was also shown that meso-enamination deeply alters the photophysical properties of the BODIPY chromophore, quenching efficiently the fluorescence by the activation of non-radiative de-excitation channels, including intramolecular charge transfer (ICT), which in turn enables singlet-oxygen generation.1 This result, easy generation of a family of BODIPYs with potentiality to act as singlet-oxygen photosensitizers for photodynamic therapy (PDT)2 without involving heavy atoms or complex polyBODIPY designs, prompted us to detailed explore the scope of such a possibility. This presentation shows the results obtained from such an exploration, by reporting the most interesting results concerning singlet-oxygen generation in a selected family of BODIPY meso-enamines. [1] Palao, E.; Montalvillo-Jiménez, L.; Esnal, I.; Prieto-Montero, R.; Agarrabeitia, A. R.; García-Moreno, I.; Bañuelos, J.; López-Arbeloa, I.; de la Moya, S.; Ortiz, M. J., Controlling Vilsmeier-Haack processes in meso-methylBODIPYs: A new way to modulate finely photophysical properties in boron dipyrromethanes. Dyes Pigments. 2017, 141, 286. [2] a) Kamkaew, A.; Lim, S. H.; Lee, H. B.; Kiew, L. V.; Chung, L. Y.; Burgess, K., BODIPY dyes in photodynamic therapy. Chem. Soc. Rev. 2013, 42, 77. b) Awuah, S. G.; You Y., Boron dipyrromethane (BODIPY)-based photosensitizers for photodynamic therapy. RSC Adv. 2012, 2, 11169.

  • A versatile fluorescent molecular probe endowed with singlet oxygen generation under white-light photosensitization

    by G. Durán-Sampedro, N. Epelde-Elezcano, V. Martínez-Martínez, I. Esnal, J. Bañuelos, I. García-Moreno, A.R. Agarrabeitia, S. de la Moya, A. Tabero, A. Lazaro-Carrillo, et al.


  • Controlling Vilsmeier-Haack processes in meso-methylBODIPYs: A new way to modulate finely photophysical properties in boron dipyrromethenes

    by Eduardo Palao-Utiel, Laura Montalvillo-Jiménez, Ixone Esnal, Ruth Prieto-Montero, Antonia R. Agarrabeitia, Inmaculada García-Moreno, Jorge Bañuelos, Iñigo López-Arbeloa, Santiago de la Moya, Maria J. Ortiz


  • Rational Design of Advanced Photosensitizers Based on Orthogonal BODIPY Dimers to Finely Modulate Singlet Oxygen Generation

    by Nerea Epelde‐Elezcano, Eduardo Palao, Hegoi Manzano, Alejandro Prieto‐Castañeda, Antonia R. Agarrabeitia, Andrea Tabero, Angeles Villanueva, Santiago de la Moya, Íñigo López‐Arbeloa, Virginia Martínez‐Martínez, et al.

    The synthesis, photophysical characterization, and modeling of a new library of halogen‐free photosensitizers (PS) based on orthogonal boron dipyrromethene (BODIPY) dimers are reported. Herein we establish key structural factors in order to enhance singlet oxygen generation by judiciously choosing the substitution patterns according to key electronic effects and synthetic accessibility factors. The photosensitization mechanism of orthogonal BODIPY dimers is demonstrated to be strongly related to their intrinsic intramolecular charge transfer (ICT) character through the spin‐orbit charge‐transfer intersystem crossing (SOCT‐ISC) mechanism. Thus, singlet oxygen generation can be effectively modulated through the solvent polarity and the presence of electron‐donating or withdrawing groups in one of the BODIPY units. The photodynamic therapy (PDT) activity is demonstrated by in vitro experiments, showing that selected photosensitizers are efficiently internalized into HeLa cells, exhibiting low dark toxicity and high phototoxicity, even at low PS concentration (0.05–5×10−6 m).